Re: How to achieve international action on falsified and substandard medicines

Article Highlights

  • Many of the most glaring problems of the WHO's pre-qualification program were resolved more than 5 years ago.

    Tweet This

  • A global treat to improve medicine quality does not depend, fortunately, on the WHO's enforcement capability.

    Tweet This

  • There is a pressing need for an international treaty to mitigate the problem of substandard drugs

    Tweet This

Subscribe to AEI's health emails
Articles and events on health policy. Published approximately twice a month.

First Name:
Last Name:
Email:
Zip Code:

Jerry Norris raises the important issue of the oversight of drug quality and the role of the World Health Organisation’s pre-qualification program (WHO PQ). He is correct that WHO PQ had significant problems early on, but teething problems were resolved more than 5 years ago, and his observations today seem dated and irrational.

"WHO -prequalified malaria medicines, while not always perfect, are significantly less likely to be substandard than their competitors." -Roger Bate and Amir AttaranFor example, Mr. Norris complains that when in 2004 WHO discovered low quality medicines being sold as prequalified, it withdrew its prequalification. That actually seems reasonable to us—or would Mr. Norris rather the alternative that WHO sweep the problem under the rug and not withdraw its prequalification?

Mr. Norris implies that because WHO is ineffectual, so would be a global treaty to improve medicine quality. That is a wild leap of illogic, and simply wrong. First, a global treaty would cover far more products than just the small number of WHO-prequalified medicines. Second, a treaty would not depend on WHO for its enforcement mechanisms (indeed, WHO is not a law enforcement agency). Third, in the limited role it plays today, WHO has achieved much to improve medicine quality. As we have shown elsewhere (http://www.dovepress.com/articles.php?article_id=10449) WHO-prequalified malaria medicines, while not always perfect, are significantly less likely to be substandard than their competitors.

We agree with Mr. Norris when he concedes that WHO processes can help bring about “a substantial mitigation of substandard drugs.” The pressing need now is for an international law mandate—basically, a treaty—to prioritize that task, not just for WHO, but for all its member states.

Roger Bate is a resident scholar at the American Enterprise Institute.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Roger
Bate
  • Roger Bate is an economist who researches international health policy, with a particular focus on tropical disease and substandard and counterfeit medicines. He also writes on general development policy in Asia and Africa. He writes regularly for AEI's Health Policy Outlook.
  • Phone: 202-828-6029
    Email: rbate@aei.org
  • Assistant Info

    Name: Katherine Earle
    Phone: (202) 862-5872
    Email: katherine.earle@aei.org

What's new on AEI

image The money in banking: Comparing salaries of bank and bank regulatory employees
image What Obama should say about China in Japan
image A key to college success: Involved dads
image China takes the fight to space
AEI on Facebook
Events Calendar
  • 21
    MON
  • 22
    TUE
  • 23
    WED
  • 24
    THU
  • 25
    FRI
Wednesday, April 23, 2014 | 12:00 p.m. – 1:30 p.m.
Graduation day: How dads’ involvement impacts higher education success

Join a diverse group of panelists — including sociologists, education experts, and students — for a discussion of how public policy and culture can help families lay a firmer foundation for their children’s educational success, and of how the effects of paternal involvement vary by socioeconomic background.

Event Registration is Closed
Thursday, April 24, 2014 | 12:00 p.m. – 1:30 p.m.
Getting it right: A better strategy to defeat al Qaeda

This event will coincide with the release of a new report by AEI’s Mary Habeck, which analyzes why current national security policy is failing to stop the advancement of al Qaeda and its affiliates and what the US can do to develop a successful strategy to defeat this enemy.

Friday, April 25, 2014 | 9:15 a.m. – 1:15 p.m.
Obamacare’s rocky start and uncertain future

During this event, experts with many different views on the ACA will offer their predictions for the future.   

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.